期刊文献+

人DNA聚合酶β全长cDNA的克隆、鉴定及真核表达载体的构建 被引量:2

Cloninng and Sequencing of the Human DNA Polymerase β Entire cDNA and Construction of Its Eukaryotic Expression Vector
在线阅读 下载PDF
导出
摘要 【目的】克隆人类DNA聚合酶 (pol β)基因全长cDNA ,构建该基因的真核高效表达载体。【方法】抽提人胚肺纤维细胞HLF总RNA进行RT PCR扩增 ,用pGEM T载体经T/A克隆、DNA测序确定后 ,用双酶切将 pol β全长cDNA定向克隆到绿色荧光蛋白表达载体 pEGFP C1,转染大肠杆菌DH5α ,筛选阳性克隆 ,双酶切鉴定重组质粒。【结果】经RT PCR获得 1 0 3kb的产物 ,经DNA测序 ,确定所扩增片段为人类 pol β基因全长cDNA ,进而成功筛选出真核表达载体 pEGFP C1 β。【结论】成功构建人 pol β基因全长cDNA真核表达载体 。 To construct an efficient Eukaryotic expression vector of human DNA polymerase β(pol β). Following total RNA being extracted from human embryo lung fibroblast HLF and RT PCR being carried out, the PCR product was cloned into pGEM T vector. The recombinant plasmid certified by sequencing. The pol β entire cDNA was cloned into expression vector pEGFP C1,and then transferred into E.coli DH5α. The recombinant plasmids were identified by restriction endonuclease enzyme analysis 1 03 kb fragment containing restriction sites on 5′ stream was obstained through RT PCR. The object fragment is homology with pol β. The recombimant plasmid pEGFP C1 β was successfully selected [Conclusion] The efficient expression vector of human pol β has been constructed, it can be used in establishing the human cell line of overexpression of pol β.
出处 《中山医科大学学报》 CSCD 北大核心 2002年第3期187-189,共3页 Academic Journal of Sun Yat-sen University of Medical Sciences
基金 国家自然科学基金资助项目 (3 0 10 0 15 2 )
关键词 DNA聚合酶Β 聚合酶链反应 DNA 重组 DNA polymerase beta polymerase chain reaction DNA, recombiant
  • 相关文献

同被引文献15

  • 1Dogliotti E, Fortini P, Pascucci B, et al. The mechanism of switching among multiple BER pathways. Prog Nucleic Acid Res Mol Bio1,2001,68 : 3-27.
  • 2Idriss HT, Al-Assar O, Wilson SH. DNA polymerase beta. Int J Biochem Cell Biol, 2002,34 : 321-324.
  • 3Srivastava DK, Husain I, Arteaga C, et al. DNA polymerase B expression differences in selected human tumors and cell lines. Carcinogenesis, 1999,20 : 1049-1054.
  • 4Canitrot Y, Frechet M, Servant L, et al. Overexpression of DNA polymerase beta:a genomic instability enhancer process. Faseb J,1999,13:1107-1111.
  • 5Canitrot Y, Cazaux C, Freehet M, et al. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proe Natl Acad Sci USA, 1998,95 : 12586-12590.
  • 6ZENG Q, SI X, HORSTMAN H, et al. Prenylation- dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome [J]. J Biol Chem, 2000, 275 (28): 21444-21452.
  • 7DIAMOND R H, CRESSMAN D E, LAZ T M, et al. PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth[J]. Mol Cell Biol, 1994, 14(6): 3752- 3762.
  • 8ZENG Q, HONG W , Tan Y H. Mouse PRL-2 and PRL-3, Two Potentially Prenylated Protein Tyrosine Phosphatases Homologous to PRL-1 [J]. Biochem Biophys Res Commun, 1998, 244(2): 421-427.
  • 9BESSETTE D C, WONG P C, PALLEN C J. PRL-3: a metastasis-associated phosphatase in search of a function [J]. Cells Tissues Organs, 2007,185(1-3):232- 236.
  • 10ACHIWA H, LAZO J S. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells [J ]. Cancer Res, 2007, 67(2): 643-650.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部